[dzeanah]

According to a CNBC interview last week the product is protected via trade secrets. People know what's in it, but not how to make it. And it's some weird stuff (I think pituitary glands from pigs or something equally weird are key components - not sure there's a lot of open-source knowledge on how to deal with that ingredient pipeline.)

The CEO's pitch was that they believe the drug is useful in more roles than it's currently used for, so they're taking the increased money to perform the studies required to allow the drug to be used to treat more diseases for which there is no alternative.

And right now this is a last-ditch drug - it's used once all other therapies have failed.

So they're trying to increase marketshare by doing expensive studies, which is why this drug is still produced and where the money is going.

At least according to the CEO, and my memory.